Albany Molecular Research, Inc. (AMRI)
26 Corporate Circle
326 articles with Albany Molecular Research, Inc. (AMRI)
Albany Molecular Research, Inc., a leading global provider of advanced contract research, development and manufacturing solutions, announced that the company is named on “America’s Best Mid-Sized Employers 2021” list published by Forbes.
Albany Molecular Research, Inc., a leading global provider of advanced contract research, development and manufacturing solutions, announced it has been recognized in the 2021 CMO Leadership Awards, presented by Outsourced Pharma and Life Science Leader.
AMRI Included in BARDA CDMO Network in Support of COVID-19 Pandemic Response in the U.S.
Albany Molecular Research Inc. (AMRI) Named Exclusive API Supplier for Recently Approved Acne Treatment
Albany Molecular Research, Inc. (AMRI) today announced that it has been named as the exclusive supplier of the active pharmaceutical ingredient (API) in Cassiopea SpA’s (SIX: SKIN) recently approved acne treatment, Winlevi® (clascoterone) cream 1%. The United States Food and Drug Administration (FDA) approved Winlevi® (clascoterone) cream 1% in August 2020, marking a significant milestone in the treatment of acne vulga
Albany Molecular Research Inc. (AMRI) to Present at Jefferies 2020 Virtual London Healthcare Conference
Albany Molecular Research, Inc., ( AMRI ), a leading global provider of advanced contract research, development and manufacturing solutions, today announced that its CEO and CFO will present a corporate overview at the Jefferies 2020 Virtual London Healthcare Conference. The presentation, to be delivered by CEO John Ratliff and CFO Jason Knoblauch , will be recorded and made available on AMRI’s website. AMRI’s execu
Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced drug development and manufacturing solutions, today announced that it has signed a supply agreement with AstraZeneca to support the manufacture of AstraZeneca’s COVID-19 vaccine candidate AZD1222, intended to
ViralClear Pharmaceuticals Partners With Albany Molecular Research Inc. (AMRI) on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the Potential Treatment of COVID-19
ViralClear Pharmaceuticals, Inc. (ViralClear), supported by Albany Molecular Research Inc. , (AMRI), a leading global contract research, development, and manufacturing organization (CDMO), is undertaking research to investigate the potential of merimepodib to fight SARS-CoV-2, the virus that causes COVID-19, either as a stand-alone treatment or in combination with other antiviral agents or immune modulators. “As p
Rensselaer, NY facility is the first and only facility to receive the top designation from SafeBridge Consultants
Michael Mulhern Appointed Chairman of AMRI Board of Directors
AMRI announced the appointment of Prakash Pandian as chief information officer (CIO).
AMRI has secured a seven-year contract from the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH).
She will report to Michael J. Mulhern, chief executive officer.
AMRI, a global pharmaceutical contract research, development and manufacturing organization, today announced the appointment of Anthony Mattacchione as senior vice president and chief financial officer, effective April 2, 2018.
The addition of a new multipurpose aseptic API line at AMRI's facility in Valladolid, Spain, enhances capacity at the site and complements its other aseptic API manufacturing plants in Bon Encontre and Tonneins, France.
AMRI today announced that Paul Feuerman has joined the company as senior VP, general counsel and head of business development and will be responsible for leading all AMRI's legal, M&A, and corporate affairs activities for the company's locations worldwide.
3ST Research Files Litigation Alleging Fraud And Conversion Of Inventor's Intellectual Property Rights By AMRI
AMRI Announces Early Termination Of HSR Waiting Period For The Carlyle Group And GTCR's Proposed Acquisition Of AMRI